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Abstract 
Objectives: We compared the magnitude and direction of associations between 
forgiveness and pain, mental and physical health, quality of life, and anger in a 
sample of fibromyalgia (FMS) patients and healthy controls. In addition, we compared 
FMS and controls on mean levels of these variables. 
Methods: 173 FMS patients and 81 controls completed this study. Patients and 
controls were residents of Germany recruited with the support of the German 
Fibromyalgia Patient Association and several self-help groups. FMS patients and 
controls were about 53 years of age, mostly married (70%), Christians (81%), with 
levels of education ranging from 9 years to 13+. All participants completed 
assessments of forgiveness, pain, health, quality of life, and anger.  
Results: Analyses revealed that FMS patients reported higher pain and anger and 
poorer health and quality of life. FMS patients also reported lower levels of both 
forgiveness of self and others. Size and direction of associations of forgiveness with 
pain, health, quality of life, and anger in were not significantly different between 
healthy individuals and patients with FMS. 
Discussion: Forgiveness of self and others is beneficially associated with pain, 
health, quality of life, and anger in FMS patients at levels that are of similar size and 
direction as in healthy controls. However, FMS patients manifest lower levels of 
forgiveness of self and others. Therapeutic promotion of forgiveness as a 
psychosocial coping strategy may help patients with FMS to better manage 
psychological and physical symptoms, thereby enhancing well-being.  
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Introduction 
Fibromyalgia syndrome (FMS) is a common and chronic syndrome of unknown 
etiology characterized by diffuse pain, increased tenderness to palpation and 
additional symptoms (e.g. disturbed sleep, fatigue and psychological distress) [1] 
resulting in major effects on function, health, work status and quality of life [2-4] as 
well as high rates of health care utilization [5]. 
It has been proposed that FMS is a complex, multidimensional disorder with both 
biomedical and psychosocial-behavioral dimensions [6]. Past research has shown 
that these two dimensions are relatively independent in different chronic pain 
syndromes, suggesting the importance of considering heterogeneity of patients in 
each of the dimensions when planning treatment [7]. Turk et al [8] have suggested, 
for example, that psychological characteristics may be important factors in the 
identification of FMS patients who are more or less likely to benefit from an 
interdisciplinary intervention and in the customization of treatment plans for individual 
patients. 
There is growing evidence that FMS is a stress-related syndrome. Studies in FMS 
have generally demonstrated altered functioning of the hypothalamic-pituitary-
adrenal (HPA) axis and autonomic nervous system (ANS) [9, 10]. However, studies 
have revealed both hypo- and hyper-activity of the hypothalamic-pituitary-adrenal 
axis and the autonomic nervous system in FMS, and often the degree of abnormality 
is small or occurs in a subgroup of patients with substantial overlap between patients 
and controls. Some researchers have proposed that FMS can in fact be viewed as a 
failed attempt of our complex adaptive system to accommodate to a perceived hostile 
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external environment. FMS is, in this view, a disease in which distress is transformed 
into pain through sympathetic nervous system hyperactivity [10]. 
These results are corroborated by FMS patients’ reports of symptom exacerbation 
when they are exposed to physical (e.g. acute infections, physical overload) or 
psychosocial stressors (e.g., bullying at work place, conflicts with partner). This 
notion has recently been endorsed by Fischer et al [11] who showed that higher 
stress at a given measurement time point (i.e. cortisol and alpha-amylase in saliva 
samples) was associated with higher reported pain levels at a subsequent time point. 
As well, it is well-established that negative emotions such as anger or hostility have 
detrimental effects on health [12]. 
Psychotherapeutic strategies for pain, including Acceptance and Commitment 
Therapy and various other cognitive behavioral therapies, aim to reduce negative 
emotions and stress resulting from pain catastrophizing, fear avoidance behaviors, 
and other maladaptive thoughts that contribute to disabling aspects of chronic pain 
[13-15]. Psychotherapy also aims to promote active coping strategies like pain 
acceptance, physical activity, and structured relaxation [16, 17]. Forgiveness might 
be a component of the larger part of the positive, health promoting thoughts, feelings, 
and behaviors encouraged by these types of therapies and could be considered an 
important target of therapy [18, 19]. Indeed, the process of forgiveness is consistent 
with and can be readily incorporated into acceptance-based treatment modalities, 
such as Acceptance and Commitment Therapy, Dialectical Behavior Therapy, and 
Mindfulness-Based Cognitive Therapy [20]. Moreover, some specific methods for 
facilitating forgiveness as a direct focus of therapy, including stand-alone forgiveness 
interventions have already been developed and have sound evidence of 
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effectiveness [21]. 
Forgiveness is a multidimensional construct [22] that can be directed toward oneself 
or others and is considered both a state and a trait. Trait forgiveness is often of 
greater interest in studies of health and well-being because it is thought to have its 
influence across time and situations and consequently has greater impact than a 
momentary state experience [23]. In healthy populations, forgiveness has been 
linked to a variety of indicators of psychological well-being including less anger, lower 
depression, and lower anxiety [24]. Forgiveness has been associated with decreased 
sympathetic arousal, increased parasympathetic tone, and improved physical health 
and longevity [25-27]. At present, only two known studies have examined forgiveness 
in pain patients. The first study examined a diverse sample of pain patients with 
various causes, locations, and durations of pain [28]. Results showed that pain 
patients’ average levels of forgiveness of self and others did not differ from a healthy 
sample, and forgiveness was related to less time in pain, less pain intensity and 
interference, and better mental health. The second study examined forgiveness in a 
sample of chronic low back pain patients and showed that forgiveness was related to 
less pain, anger, and psychological distress [29]. The salutogenic associations with 
pain, health, and anger are likely due to the coping benefits of forgiveness [30] that 
impact the stress-disease connection [31]. Dealing with adversities of life through 
forgiveness may be especially useful for individuals with fibromyalgia who are 
interpersonally distressed [6, 32] as forgiveness applies well to inter-relational 
challenges in multiple life-domains that patients commonly struggle with [33]. 
Forgiveness and pain, mental and physical health, quality of life, and anger have not 
been previously examined simultaneously in fibromyalgia patients compared to 
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controls, and this was the goal of the current study. Based on the above review of the 
literature, we hypothesized that, compared to controls, FMS patients would show 
higher pain, anxiety, depression, and anger, lower levels of health and quality of life, 
and equal levels of forgiveness of self and others. Because FMS is a stressful 
condition and forgiveness has been proposed to be useful for managing the stresses 
of FMS [32, 34], it was hypothesized that the beneficial associations of forgiveness 
with pain, health, quality of life, and anger outcomes that have been demonstrated in 
other pain patients and healthy populations would extend to patients with FMS. 
Hence, beneficial associations of forgiveness with pain, health, quality of life, and 
anger should not be different for controls versus FMS patients. 
Materials and Methods 
Patients and controls 
In total 320 questionnaire sets were sent out to several fibromyalgia self-help groups 
which were recruited with the support of the German Fibromyalgia Patient 
Association. 173 patients (response rate = 54%) filled out the set. The group leaders 
were contacted by the first author (MO) and were then sent the patient materials 
including the questionnaires, an information letter regarding the study objectives, and 
a consent form. Group leaders were asked to distribute the materials and to collect 
and return them when completed. Healthy controls (N = 81) were a German 
convenience sample of volunteers without fibromyalgia that completed the 
questionnaire set. Controls were recruited using similar snowball sampling methods 
to reach individuals of a variety of ages. Initial surveys were delivered to students 
who then delivered surveys to people they knew. 
Measures 
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Forgiveness of Self and Others. The forgiveness of self and others scales, 
originally developed by Mauger et al [35], consist of 30 items. They are designed to 
assess general tendencies toward a forgiving disposition with regard to both oneself 
(e.g., `I feel guilty because I don’t do what I should for my loved ones`) and others 
(e.g., `It is hard for me to forgive those who hurt me`). Forgiveness of self is 
measured with 15 items, and forgiveness of others is measured with 15 items. Each 
item is responded to on a 1 (strongly disagree) to 5 (strongly agree) response scale. 
Both scale scores range from 15 to 60 and possess acceptable reliability and good 
construct validity [35]. Higher scores indicate higher forgiveness. Because there is no 
German version of the forgiveness scales, a back-forward translation from English 
according to scientific guidelines was performed [36]. Mauger’s original psychometric 
analyses were replicated to evaluate the translated German instrument. Mauger 
reported internal consistency of English forgiveness of self and others scales to be 
.82 and .79, respectively, and the present study estimates from the German scales 
were .88 and .81, respectively. Mauger reported correlations of forgiveness of self 
and others with age, sex, and education that ranged between -.06 and -.21, and 
present study estimates similarly ranged between .09 and -.21. Translation to 
German appears to have not affected the integrity of the scales and psychometric 
estimates are similar or better than the original English version. 
Pain. Duration of symptoms in years, and current and past (last three month) pain 
levels, were measured on a numerical rating scale from 0 (no pain) to 10 (extreme 
pain). Pain severity (range 0-120) and distribution (range 0-24) were assessed with 
the regional pain scale [37]. Higher scores indicate higher levels of pain. 
Hospital Anxiety and Depression Scale. The Hospital Anxiety and Depression 
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Scale is a brief (14 item) self-report questionnaire measuring anxiety and depression 
[38]. It was developed for use in general medical out-patient clinics but is now widely 
used in clinical practice and research. The Hospital Anxiety and Depression Scale 
has good reliability and construct validity [39]. Responses are based on the relative 
frequency of symptoms over the past week, using a four point Likert scale ranging 
from 0 (not at all) to 3 (very often). The total score for each of the depression and 
anxiety scales can range from 0 to 21 and higher scores indicate higher depression 
and anxiety. 
Quality of Life Scale. The Quality of Life Scale is a 16 item questionnaire designed 
specifically for use in chronic disease patients including patients with fibromyalgia 
[40]. Items assess various aspects of life such as physical and material well-being, 
relationships with other people, social, community, and civic activities, personal 
development and fulfillment, recreation, and independence. Satisfactory construct 
validity has been shown for the German version in a sample of fibromyalgia patients 
[41]. The items are scaled from 1 to 7 and aggregated into a sum score where a 
higher score indicates higher quality of life (possible sum score range 16-112).
Short Form 12. The Short Form 12 is a multidimensional general measurement 
instrument assessing health-related quality of life. It has become widely used in 
clinical trials and as a standard outcome assessment instrument because of its 
brevity and psychometric performance [42]. Both mental and physical health 
composite scores were used in this study ranging from 0 to 100 with higher scores 
indicating better mental and physical health. 
State-Trait Anger Inventory-II. The State-Trait Anger Inventory-II is one of the most 
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widely used measures of anger [43]. It contains five subscales measuring: 1) state 
anger (raw score range 10-40), 2) trait anger (10-40), 3) anger-in (holding in or 
suppressing) (8-32), 4) anger-out (expressing anger toward other people or objects in 
environment) (8-32), and 5) anger-control (controlling retention or expression of 
anger) (8-32). The STAXI-2 contains 57 items responded to on a 1 (almost never) to 
4 (almost always) response scale with higher scores indicating higher levels of anger. 
Socio-demographics. Age, education, religion, sex and marital status were 
assessed. Two questions concerning the degree of religiosity (How religious are 
you?) and spirituality (How spiritual are you?) were included. The latter were 
measured with an 11-point rating scale (0=not religious/spiritual at all to 
10=extremely religious/spiritual). 
Statistical analysis
One way multivariate analyses of covariance were used to examine FMS patient 
versus control differences on all health and well-being outcome variables while 
holding constant the effects of age, marital status, education, religiosity, and 
spirituality. Subsequent univariate one way analyses of covariance were computed 
on each separate outcome. Wilk’s lambda and F statistics are reported for the 
multivariate test and F is reported for the univariate tests. Partial eta squared (ηp2) is 
reported as the effect size for both multivariate and univariate tests. Partial 
correlations (rp) controlling socio-demographic and religious/spiritual variables, are 
reported for associations between forgiveness and health and well-being outcomes 
and to determine if the healthy associations expected to be present in control 
participants extended to FMS patients. Differences between FMS patients and 
controls in the magnitude of partial correlations were assessed using Cohen’s Z-test 
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for differences between independent correlation coefficients [44]. Missing data was 
imputed using expectation maximization (EM) methods. Prior to imputation, missing 
data were determined to be missing at random. Missing values on any given variable 
were not related to missing values on any other variable (average r = .11). Results 
remain substantively unchanged in original and imputed datasets. Statistical 
significance was set at p < .05. 
Results 
Socio-demographic analyses 
Patients and controls did not differ in terms of religious affiliation (i.e., mostly 
Christian) or sex (i.e., mostly female) (see Table 1). Patients were about 12 years 
older, less likely to be single and living alone, more likely to have been widowed, less 
educated, and more religious and spiritual.  
Main analyses 
As hypothesized, there was a large difference between FMS patients and controls on 
the overall multivariate composite of pain, anxiety, depression, anger, health, and 
quality of life (λ = .19, F(14, 234) = 69.28, p < .001, ηp2 = .81). Not as hypothesized, 
there was a moderate difference between FMS patients and controls on the overall 
multivariate composite of forgiveness of oneself and others (λ = .92, F(2, 246) = 
10.90, p < .001, ηp2 = .08). Examining the univariate tests (see Table 2) revealed that 
the largest differences between FMS patients and controls were on pain and physical 
health followed by mental health and quality of life. Differences on anger and 
forgiveness were smaller but statistically significant. Differences on anger out and 
anger control were not statistically significant. 
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Partial correlations (rp) between forgiveness and all outcomes are presented in Table 
3. Associations between forgiveness of self and severity and number of regions of 
pain approached statistical significance (ps < .10) for both FMS patients and controls. 
Statistically significant correlations between forgiveness of self and mental health, 
quality of life, and anger ranged between -.23 to -.56 for FMS patients and between -
.45 to -.62 for controls (see Table 3). Statistically significant correlations between 
forgiveness of others and mental health, quality of life, and anger ranged between -
.19 to -.48 for FMS patients and between -.21 to -.55 for controls. Magnitude of 
associations of forgiveness of self and others with all outcomes did not differ 
significantly (Zs < 1.96, ps > .05) between FMS patients and controls.   
Discussion 
This is the first study, to our knowledge, to compare levels of forgiveness of oneself 
and others between FMS patients and controls. It is also the first time that the 
associations between forgiveness and pain, health, quality of life, and anger have 
been examined and directly compared between FMS patients and controls to 
examine the robustness of potentially beneficial associations between forgiveness 
and these outcomes.  
Confirming prior research, FMS patients showed significantly higher levels of pain, 
anxiety, depression, and anger, and lower levels of health and quality of life, as 
compared to controls [1-5]. A new finding though was small to moderate and 
statistically significant differences between FMS patients and controls on forgiveness. 
FMS patients showed lower levels of forgiveness of oneself and others compared to 
controls. Given the number of interpersonal stressors and challenges that FMS 
patients face [32], it is important to consider that lower forgiveness may be an 
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important point of intervention for coping with these experiences. Most associations 
between forgiveness of self and others with anxiety, depression, anger, health, and 
quality of life were statistically significant, in the predicted direction, of moderate size, 
and consistent in direction and magnitude with much previous research in pain 
patients and healthy populations [28, 29, 45]. Associations between forgiveness of 
self and pain severity and number of pain regions approached statistical significance 
and remain clinically significant issues to address. There were no differences 
between FMS patients and controls in the magnitude of associations suggesting that 
potentially beneficial associations of forgiveness with these outcomes is equally 
available to patients with FMS as the healthy. 
As compared to forgiveness of others, associations between forgiveness of self and 
pain, anxiety, depression, anger, health, and quality of life were stronger in both 
patients and controls. This is consistent with previous research [46, 47] in healthy 
populations and may reflect the especially difficult and chronic nature of not forgiving 
oneself. In essence, when an individual is considered one’s own offender, it may be 
very difficult to escape lingering feelings of guilt, shame, and remorse and this may 
be associated with poor health and well-being [48]. Because one cannot escape 
oneself as an offender this might be a constant reminder of wrongdoing that 
stimulates continued guilt, shame, and remorse that may become a self-focused 
ruminative style. Self-forgiveness may, more so than forgiveness of others, offer the 
relief needed most from perfectionistic [49] and self-critical and uncompassionate 
tendencies [50, 51].  
FMS patients exhibited significantly lower forgiveness of others and self, compared to 
controls. Recently the role of forgiveness in chronic pain and FMS [33] has been 
13 
comprehensively reviewed and several identified biographical incidents and life 
domains where (the lack of) forgiveness could potentially play a role in FMS patient 
groups has been discussed including, to name only a few, family, workplace, social 
situations, and medical interactions. This list, however, provides only a brief mention 
of some of the most obvious places where forgiveness might offer helpful relief for 
FMS patients, and other domains certainly exist (e.g., sociocultural stigma).   
Knowing that forgiveness is lower in FMS patients, and yet, that its potential for 
benefiting pain, health, and quality of life is equally strong for these patients as for 
healthy controls, invites the question of how to promote forgiveness in FMS patients. 
Unfortunately, limited attention has been devoted to designing FMS-specific 
programs for enhancing forgiveness as part of a means of ensuring good mental 
health and quality of life in these patients. Two small scale studies [34, 52] suggest 
that forgiveness promotion can be systematically delivered and well-received by FMS 
patients and that these patients can enjoy and benefit (e.g. mental health) from the 
experience. More extensive forgiveness education research is required to fully 
address this issue in order to provide evidence-based programs to support the 
development of this coping skill in patients. Perhaps evidence-based forgiveness 
psycho-educational programs that have been repeatedly proven to be beneficial in 
healthy populations [53, 54] will be adopted and more regularly used in both clinical 
treatment and research with FMS patients. Similarly, focused clinical and research 
efforts incorporating the process of forgiveness into conceptually-related treatments 
(e.g., acceptance-based modalities) [20] will likely prove useful. These methods, 
whether stand-alone or conceptually-related interventions, offer effective techniques 
for facilitating empathy, compassion, altruism, and commitment, which are in and of 
themselves likely to be helpful to FMS patients, but all the more so to the extent that 
14 
these experiences promote forgiveness and its health benefits. Given the growing 
evidence that forgiveness is connected to health [15, 22, 31], promoting forgiveness 
in FMS patients may offer new avenues for encouraging healthy adjustment and 
health. 
As with all observational studies, the present investigation has some limitations. First, 
our measurements are based on self-reports and response bias (i.e., faking good) is 
a possibility. Second, as an observational study, causal inferences cannot be made 
but can only be suggested or theorized. Third, this is a self-selected sample from only 
one region of the world. Last, forgiveness may reflect other positive coping strategies 
(e.g., problem-focused coping) and our analyses do not control these variables. 
To conclude, forgiving oneself and others is one aspect of psychosocial care in FMS 
that could potentially be used to help promote enhanced mental health and quality of 
life and reduced anger. The present findings indicate that FMS patients report lower 
forgiveness of self and others than healthy controls, and yet, the beneficial 
associations of forgiveness with mental health, quality of life, and anger are equally 
strong in FMS patients as in healthy controls. Our findings may have clinical 
implications; bolstering forgiveness levels in FMS patients may result in 
improvements in other areas of healthy functioning for FMS patients. While future 
randomized controlled studies will have to bear out cause-and-effect relationships, 
this initial work provides the first known evidence that forgiveness is lower in FMS 
patients and that beneficial associations with pain, health, and quality of life are 
present and not diminished by FMS. Continued attention to building psychosocial 
resources for coping with FMS will bring greater attention to protective mechanisms 
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such as forgiveness that hold potential to ameliorate symptoms of pain and 
psychological distress and improve quality of life. 
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Table 1. Socio-Demographic Summary Statistics for Fibromyalgia Patients and 
Controls 
Patients Controls F/χ2 p
Age in years1 58 (8.8) 47 (14.2) 57.76 < .001 
Gender (female/male)2 161/9 76/5 .09 .78 
Religion2
  Christian 
  Muslim 
..Other 
  No religion 
138 
1 
1 
30 
65 
4 
0 
12 
5.96 .11 
Marital status2
  Married/with partner 
  Single 
  Widowed/divorced  
130 
8 
32 
59 
8 
11 
14.26 < .01 
Education (years)2
  9 or less 
  10 or 11 
  12 or more 
  Advanced 
74 
65 
16 
12 
7 
23 
44 
5 
68.76 < .001 
How religious are you?1 4.9 (2.7) 4.1 (2.7) 5.29 .02 
How spiritual are you?1  3.8 (2.8) 3.0 (2.8) 4.72 .03 
1Mean (standard deviation) and F-test; 2N and Chi-square test 
23 
Table 2. Means and Standard Errors for Fibromyalgia Patients and Controls on Pain, Mental and Physical Health, Quality of Life, 
Anger, and Forgiveness 
* p < .05, *** p < .001 
Controls FMS 
M SE M SE F ηp2
Pain Today .69 .20 6.10 .13 449.33 *** .65 
Pain Severity (Last 3 mos) .90 .20 6.78 .13 518.49 *** .68 
Regional Pain Scale - Severity 2.33 1.21 31.84 .77 364.08 *** .60 
Regional Pain Scale - Number of Regions 1.58 .44 14.18 .28 501.50 *** .67 
Anxiety 5.05 .52 10.47 .34 65.36 *** .21 
Depression 2.90 .45 9.31 .29 121.60 *** .33 
Quality of Life 89.13 2.02 66.06 1.29 79.44 *** .24 
SF-12 Physical Health 54.50 .80 30.14 .51 572.15 *** .70 
SF-12 Mental Health 50.77 1.09 35.71 .70 116.00 *** .32 
STAXI State Anger 11.74 .75 15.29 .48 13.71 *** .06 
STAXI Trait Anger 19.50 .66 21.59 .42 6.06 * .02 
STAXI Anger In 15.42 .62 20.38 .40 38.88 *** .14 
STAXI Anger Out 13.57 .50 13.41 .32 0.06  .00 
STAXI Anger Control 23.08 .54 22.28 .34 1.38  .01 
Forgiveness of Others 41.58 1.14 38.33 .73 5.00 * .02 
Forgiveness of Self 44.61 1.38 36.52 .88 21.13 *** .08 
